Sells food-safety tests and animal-health products to food and feed processors, livestock producers, and veterinary and animal-health distribution channels.
10-K for FY2026, filed Jul 30, 2026Neogen Corporation and its subsidiaries develop, manufacture and market a diverse line of products and services dedicated to food and…View ↗
Neogen’s Animal Safety segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments…View ↗
Neogen’s staff of specialized animal safety sales, marketing, customer and technical service representatives sell our products and services…View ↗
Customers buy shipped diagnostic kits and animal products and use genomics and commercial laboratory services; payment terms for products and services are generally 30 to 90 days.
10-K for FY2026, filed Jul 30, 2026Product revenue consists primarily of shipments of:View ↗
Consumable products marketed to veterinarians, retailers, livestock producers and animal health product distributors; andView ↗
Genomic identification and related interpretive bioinformatic services; andView ↗
Other commercial laboratory services.View ↗
Payment terms for products and services are generally 30 to 90 days.View ↗
10-K for FY2026, filed Jul 30, 2026
FY2026 revenue by product or service ↗$870.4M
10-K for FY2026, filed Jul 30, 2026
$870.4M ↗| Segment | Share | Revenue | How money arrives |
|---|---|---|---|
|
Product Revenues
Sold outright
10-K for FY2026, filed Jul 30, 2026 |
88%
FY2023: 87%
|
Product Revenues, FY2026
$768.2M Sources
|
Sold outright |
|
Service Revenues
|
12%
FY2023: 13%
|
Service Revenues, FY2026
$102.2M Sources
|
Food and feed producers, processors, laboratories, and regulators buy food-safety solutions directly or through distributors. Livestock producers, veterinarians, and retailers buy animal-safety products directly or through dealers and distributors.
10-K for FY2026, filed Jul 30, 2026Neogen’s Food Safety segment is primarily engaged in the manufacturing and marketing of diagnostic solutions, test kits, consumables, and…View ↗
To reach each customer and prospect with expertise and experience, Neogen has a staff of specialized food safety sales and technical…View ↗
Neogen’s staff of specialized animal safety sales, marketing, customer and technical service representatives sell our products and services…View ↗
Not on paper. It lost $7.9M in FY2026, but brought in more cash than it spent: $31.9M of free cash flow.
10-Q for Q1 FY2027, filed Oct 7, 2026
−$11.9MView ↗
10-Q for Q1 FY2027, filed Oct 7, 2026
Open tableView ↗
Growing. Revenue grew 65% in 4 years, from $527.2M in FY2022 to $870.4M in FY2026, about 13% a year.
Cleaners and disinfectants
Animal Safety included cleaners and disinfectants in the older report; the latest report says Neogen divested that business.
10-K for FY2023, filed Aug 15, 2023 10-K for FY2026, filed Jul 30, 2026Neogen’s Animal Safety segment is engaged in the development, manufacture, marketing, and distribution of veterinary instruments…View ↗
Neogen’s Animal Safety segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments…View ↗
Proposed genomics sale
The older report described genomics testing as part of Animal Safety; the latest report says Neogen agreed to sell that business, subject to closing conditions and regulatory approvals.
10-K for FY2023, filed Aug 15, 2023 10-K for FY2026, filed Jul 30, 2026Neogen’s Animal Safety segment is engaged in the development, manufacture, marketing, and distribution of veterinary instruments…View ↗
On March 2, 2026, Neogen Corporation announced that it had entered into a definitive agreement to sell its Genomics business to Zoetis Inc.…View ↗
Loading...